TULSA, Okla. -- Ionic Electromagnetic Technology Significantly Reduces Amputation for Millions of Diabetics, Relieves Carpal Tunnel Syndrome and Reduces or Eliminates Pain in 83 Other Medical Conditions
MicroVas(R) Technologies, Inc. announced today that it has been issued a patent by the United States Patent Office for an electromagnetic technology that will relieve pain in millions of people with vascular conditions. The potential savings in medical costs will be in the billions and millions of people will experience medical relief.
According to Health and Human Services Secretary Tommy Thompson, the United States is seeing the beginning of an epidemic that will have profound medical and economic consequences.
The MicroVas system is a solid-state electronic device that delivers a proprietary electromagnetic force field to the affected part of the body using a set of "leads" that connect the device to the patient with temporary stick-on "emitter pads." The treatment increases the amount of blood-oxygen that flows through the capillaries to the area of injury or wound. Oxygen is the key to effective and quick healing.
Wayne Buchner, MicroVas' inventor and the company's founder and CEO in commenting about the technology's development explained, "As a fourth generation Oklahoman, I saw first hand the devastation that diabetes was taking on the American Indian population in Southern Oklahoma. Literally every day people's extremities were being amputated at the Indian Health Centers. Working with area physicians, we treated over a thousand Native Americans free of charge for over five years. MicroVas Vascular Therapy is a mission for us. Our goal is to make this treatment available to everyone who needs it."
MicroVas Vascular Therapy is safe, non-invasive and causes no harmful side effects. Used two to three times per week, a typical treatment session lasts 45 minutes during which patients rest comfortably in a recliner-type chair. The total number of treatment sessions can vary from only a few up to 30 or more depending upon the condition and its severity. MicroVas Vascular Therapy is Medicare approved and covered by most private insurance plans.
18 million Americans now suffer from diabetes and the number is growing at an alarming rate. To underscore this point, the government recently doubled its estimate of Americans considered "pre-diabetic" to a staggering 41 million. Without major changes in lifestyle and diet, members of this group will develop the full-blown disease within ten years.
